Background: Amenorrhea, oligomenorrhea, and irregular uterine bleeding are a few of the many clinical signs of anovulation, which is fairly prevalent. Anovulation can result from a number of mechanisms. Polycystic ovarian syndrome (PCOS), which has clinical repercussions and is the most prevalent chronic anovulatory illness, affects 6 to 10% of people worldwide. While a variety of factors may eventually lead to PCOS, a number of therapeutic strategies have been documented in the literature, frequently without addressing the underlying reason. Ovulation Induction (OI) is a series of methods used by PCOS-afflicted women who want to get pregnant but are unable to do so naturally. Aim: The current review discusses OI in PCOS-affected women, with an emphasis on their effectiveness and application. Development: Cochrane Central Register of Controlled Trials, PubMed/MEDLINE, and EMBASE, up to November 2022, search by keyword of “Polycystic Ovarian Syndrome" and “Ovulation Induction". Conclusion: The likelihood of a good pregnancy outcome in PCOS patients receiving OI should be able to be determined by clinicians, taking into account age, body weight, the various protocols employed, and the length of infertility. A recommendation to a specialised fertility clinic for in vitro fertilisation would be a good backup plan if the aforementioned therapies don't succeed in conceiving a child. Future research should evaluate the results of the various OI techniques outlined above and stratify the efficiency of laparoscopic ovarian drilling in comparison to current medical therapy.